If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

JAZZ Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $24,122,859.21

Jazz Pharmaceuticals Insider Trading History Chart

Jazz Pharmaceuticals Share Price & Price History

^$145.81

▲ +0.89 (0.61%)

As of 03/31/2023 01:12 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Jazz Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2023	Patricia Carr	CAO	Sell	1,023	$133.22	$136,284.06	6,286
3/8/2023	Kim Sablich	EVP	Sell	3,013	$139.74	$421,036.62	30,560
3/7/2023	Kenneth W O'keefe	Director	Sell	2,690	$138.39	$372,269.10	22,889
3/6/2023	Finbar Larkin	SVP	Sell	1,706	$143.92	$245,527.52	23,854
3/5/2023	Patricia Carr	CAO	Sell	1,148	$140.76	$161,592.48	7,309
2/1/2023	Bruce C. Cozadd	CEO	Sell	1,000	$155.79	$155,790.00	367,078
1/3/2023	Bruce C. Cozadd	CEO	Sell	3,000	$159.86	$479,580.00	368,078
1/3/2023	Samantha Pearce	SVP	Sell	531	$159.59	$84,742.29	11,309
12/21/2022	Renee D Gala	CFO	Sell	2,635	$160.00	$421,600.00	32,558
12/13/2022	Samantha Pearce	SVP	Sell	531	$155.45	$82,543.95	11,309
12/9/2022	Robert Iannone	EVP	Sell	1,844	$151.54	$279,439.76	36,316
12/5/2022	Patricia Carr	CAO	Sell	63	$152.06	$9,579.78	5,934
12/2/2022	Jennifer E Cook	Director	Sell	420	$154.68	$64,965.60	5,471
12/1/2022	Bruce C. Cozadd	CEO	Sell	1,000	$157.00	$157,000.00	371,078
11/22/2022	Patrick G. Enright	Director	Sell	4,974	$149.48	$743,513.52	19,112
11/14/2022	Finbar Larkin	SVP	Sell	197	$149.33	$29,418.01	19,409
11/10/2022	Bruce C. Cozadd	CEO	Sell	2,000	$150.00	$300,000.00	372,028
11/10/2022	Samantha Pearce	SVP	Sell	1,063	$155.00	$164,765.00	11,309
10/3/2022	Bruce C. Cozadd	CEO	Sell	45,185	$134.93	$6,096,812.05	374,028
9/7/2022	Finbar Larkin	SVP	Sell	63	$150.00	$9,450.00	19,606
9/6/2022	Bruce C. Cozadd	CEO	Sell	7,703	$153.18	$1,179,945.54	353,311
8/18/2022	Peter Gray	Director	Sell	8,000	$158.00	$1,264,000.00	14,234
8/15/2022	Patricia Carr	CAO	Sell	2,142	$160.06	$342,848.52	5,934
8/4/2022	Samantha Pearce	SVP	Sell	531	$155.00	$82,305.00	11,309
8/1/2022	Bruce C. Cozadd	CEO	Sell	7,301	$154.31	$1,126,617.31	354,311
7/12/2022	Samantha Pearce	SVP	Sell	532	$155.00	$82,460.00	11,309
7/5/2022	Bruce C. Cozadd	CEO	Sell	8,775	$157.28	$1,380,132.00	351,912
7/5/2022	Christopher J. Tovey	COO	Sell	5,209	$160.00	$833,440.00	14,663
6/27/2022	Samantha Pearce	SVP	Sell	8,508	$155.00	$1,318,740.00	11,309
6/8/2022	Samantha Pearce	SVP	Sell	8,487	$155.00	$1,315,485.00	11,309
6/6/2022	Kim Sablich	EVP	Sell	1,388	$152.15	$211,184.20	27,195
6/6/2022	Neena M. Patil	Insider	Sell	1,000	$152.15	$152,150.00	31,600
6/1/2022	Bruce C. Cozadd	CEO	Sell	6,362	$146.87	$934,386.94	351,987
5/11/2022	Patricia Carr	CAO	Sell	722	$147.51	$106,502.22	6,234
5/9/2022	Anne Oriordan	Director	Sell	466	$148.95	$69,410.70	9,245
5/9/2022	Finbar Larkin	SVP	Sell	1,747	$148.94	$260,198.18	19,462
5/9/2022	Patricia Carr	CAO	Sell	1,067	$148.94	$158,918.98	7,229
5/6/2022	Neena M. Patil	Insider	Sell	296	$153.92	$45,560.32	32,677
5/2/2022	Bruce C. Cozadd	CEO	Sell	7,260	$156.63	$1,137,133.80	348,502
4/4/2022	Bruce C. Cozadd	CEO	Sell	10,772	$158.33	$1,705,530.76	346,062
2/1/2022	Bruce C. Cozadd	CEO	Sell	6,372	$139.23	$887,173.56
12/2/2021	Mark Douglas Smith	Director	Sell	417	$121.30	$50,582.10
12/1/2021	Bruce C. Cozadd	CEO	Sell	6,748	$122.66	$827,709.68
11/12/2021	Finbar Larkin	SVP	Sell	197	$135.79	$26,750.63
11/11/2021	Kim Sablich	EVP	Sell	2,748	$135.01	$371,007.48
11/1/2021	Bruce C. Cozadd	CEO	Sell	6,556	$134.75	$883,421.00
10/4/2021	Bruce C. Cozadd	CEO	Sell	6,598	$129.87	$856,882.26
9/8/2021	Finbar Larkin	SVP	Sell	63	$134.51	$8,474.13
8/6/2021	Patricia Carr	SVP	Sell	157	$147.96	$23,229.72	6,035
8/5/2021	Elmar Schnee	Director	Sell	1,632	$154.00	$251,328.00
8/2/2021	Bruce C. Cozadd	CEO	Sell	1,750	$169.98	$297,465.00	307,388
7/1/2021	Bruce C. Cozadd	CEO	Sell	10,850	$180.67	$1,960,269.50	308,888
5/5/2021	Bruce C. Cozadd	CEO	Sell	500	$170.00	$85,000.00	321,841
5/3/2021	Bruce C. Cozadd	CEO	Sell	1,500	$164.24	$246,360.00	321,841
4/1/2021	Bruce C. Cozadd	CEO	Sell	1,500	$164.96	$247,440.00	323,341
2/3/2021	Bruce C. Cozadd	CEO	Sell	1,500	$156.79	$235,185.00
1/4/2021	Bruce C. Cozadd	CEO	Sell	7,950	$162.01	$1,287,979.50	319,532
12/4/2020	Patricia Carr	VP	Sell	62	$152.55	$9,458.10
12/3/2020	Bruce C. Cozadd	CEO	Sell	250	$150.00	$37,500.00
12/1/2020	Bruce C. Cozadd	CEO	Sell	1,000	$140.58	$140,580.00
11/12/2020	Patrick G. Enright	Director	Sell	9,929	$146.72	$1,456,782.88	27,074
11/6/2020	Finbar Larkin	SVP	Sell	197	$151.93	$29,930.21	13,964
11/4/2020	Paul L. Berns	Director	Sell	4,691	$150.42	$705,620.22	14,431
11/2/2020	Bruce C. Cozadd	CEO	Sell	1,000	$145.13	$145,130.00	331,180
10/1/2020	Bruce C. Cozadd	CEO	Sell	4,500	$141.94	$638,730.00	332,180
9/9/2020	Finbar Larkin	SVP	Sell	63	$138.53	$8,727.39
9/1/2020	Bruce C. Cozadd	CEO	Sell	500	$134.90	$67,450.00	336,680
8/27/2020	Bruce C. Cozadd	CEO	Sell	3,000	$130.00	$390,000.00
8/12/2020	Patricia Carr	VP	Sell	142	$123.80	$17,579.60	6,200
8/7/2020	Patricia Carr	VP	Sell	158	$125.87	$19,887.46	6,342
6/5/2020	Patricia Carr	VP	Sell	138	$124.00	$17,112.00
5/27/2020	Seamus Mulligan	Director	Buy	50,000	$117.31	$5,865,500.00	1,117,788

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Jazz Pharmaceuticals (NASDAQ:JAZZ)

89.79% of Jazz Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Jazz Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/10/2023	Victory Capital Management Inc.	546,959	$87.14M	0.1%	-32.2%	0.864%
3/6/2023	Rockefeller Capital Management L.P.	38,810	$6.18M	0.0%	+4.7%	0.061%
2/28/2023	Voya Investment Management LLC	49,406	$7.87M	0.0%	-25.5%	0.078%
2/22/2023	Teachers Retirement System of The State of Kentucky	156,270	$24.90M	0.3%	+0.5%	0.248%
2/21/2023	Macquarie Group Ltd.	30,377	$4.84M	0.0%	+11.0%	0.048%
2/21/2023	Northwestern Mutual Wealth Management Co.	2,420	$0.39M	0.0%	-3.2%	0.004%
2/17/2023	Truist Financial Corp	36,260	$5.78M	0.0%	+6.6%	0.058%
2/17/2023	Compass Wealth Management LLC	6,985	$1.11M	0.4%	N/A	0.011%
2/16/2023	Alliancebernstein L.P.	98,191	$15.64M	0.0%	-21.9%	0.156%
2/16/2023	Caligan Partners LP	1,000	$0.16M	0.1%	N/A	0.002%
2/16/2023	State of Wyoming	1,544	$0.25M	0.1%	+53.8%	0.002%
2/15/2023	CI Private Wealth LLC	18,459	$2.94M	0.0%	N/A	0.029%
2/15/2023	Systematic Financial Management LP	200,516	$31.94M	1.0%	-0.5%	0.318%
2/15/2023	Utah Retirement Systems	10,836	$1.73M	0.0%	+0.9%	0.017%
2/15/2023	Captrust Financial Advisors	4,750	$0.76M	0.0%	-3.2%	0.008%
2/15/2023	True Wealth Design LLC	5,013	$0.80M	0.4%	N/A	0.008%
2/15/2023	Toroso Investments LLC	2,527	$0.40M	0.0%	+28.6%	0.004%
2/15/2023	Signet Financial Management LLC	12,891	$2.05M	0.4%	-3.7%	0.020%
2/15/2023	State of Wisconsin Investment Board	57,166	$9.11M	0.0%	+58.6%	0.091%
2/15/2023	Summit Partners Public Asset Management LLC	42,214	$6.73M	0.4%	-67.5%	0.067%
2/15/2023	Legal & General Group Plc	480,728	$76.59M	0.0%	-2.1%	0.763%
2/15/2023	Millennium Management LLC	476,146	$75.86M	0.0%	-14.2%	0.756%
2/15/2023	Morgan Stanley	703,993	$112.15M	0.0%	+4.2%	1.118%
2/15/2023	Man Group plc	30,093	$4.79M	0.0%	+1,665.0%	0.048%
2/15/2023	Mariner LLC	6,205	$0.99M	0.0%	+8.9%	0.010%
2/15/2023	Nissay Asset Management Corp Japan ADV	7,146	$1.14M	0.0%	-3.6%	0.011%
2/15/2023	Evergreen Capital Management LLC	17,852	$2.84M	0.1%	-2.3%	0.028%
2/15/2023	Eqis Capital Management Inc.	3,238	$0.52M	0.1%	-25.4%	0.005%
2/15/2023	Fjarde AP Fonden Fourth Swedish National Pension Fund	35,147	$5.60M	0.1%	+18.2%	0.056%
2/15/2023	Fortis Capital Advisors LLC	876	$0.14M	0.1%	N/A	0.001%
2/15/2023	AQR Capital Management LLC	111,217	$17.58M	0.0%	+245.3%	0.177%
2/15/2023	Avidity Partners Management LP	727,541	$115.91M	2.5%	+128.6%	1.155%
2/15/2023	Caisse DE Depot ET Placement DU Quebec	65,751	$10.48M	0.0%	-10.7%	0.104%
2/14/2023	Point72 Asset Management L.P.	11,800	$1.88M	0.0%	-97.0%	0.019%
2/14/2023	Vident Investment Advisory LLC	20,200	$3.22M	0.1%	-5.2%	0.032%
2/14/2023	Advisor Partners II LLC	1,357	$0.22M	0.0%	N/A	0.002%
2/14/2023	Price T Rowe Associates Inc. MD	32,963	$5.25M	0.0%	+2.8%	0.052%
2/14/2023	Verition Fund Management LLC	2,006	$0.32M	0.0%	-54.1%	0.003%
2/14/2023	Cetera Advisor Networks LLC	1,794	$0.29M	0.0%	N/A	0.003%
2/14/2023	Amundi	163,904	$25.39M	0.0%	+0.6%	0.260%
2/14/2023	Marshall Wace LLP	12,198	$1.94M	0.0%	N/A	0.019%
2/14/2023	Two Sigma Advisers LP	209,200	$33.33M	0.1%	+82.2%	0.332%
2/14/2023	Campbell & CO Investment Adviser LLC	8,041	$1.28M	0.3%	-9.0%	0.013%
2/14/2023	Two Sigma Investments LP	239,568	$38.17M	0.1%	+615.1%	0.380%
2/14/2023	Arrowstreet Capital Limited Partnership	684,517	$109.05M	0.2%	+36.4%	1.087%
2/14/2023	Engineers Gate Manager LP	5,115	$0.82M	0.0%	-81.5%	0.008%
2/14/2023	Penserra Capital Management LLC	15,550	$2.48M	0.1%	+47.0%	0.025%
2/14/2023	Qtron Investments LLC	4,000	$0.64M	0.1%	+78.9%	0.006%
2/14/2023	Quantinno Capital Management LP	21,651	$3.45M	0.3%	+264.5%	0.034%
2/13/2023	Pathstone Family Office LLC	1,687	$0.27M	0.0%	-47.2%	0.003%
2/13/2023	Advisors Asset Management Inc.	10,290	$1.64M	0.0%	+87.8%	0.016%
2/13/2023	First Republic Investment Management Inc.	12,062	$1.92M	0.0%	+0.7%	0.019%
2/13/2023	Charles Schwab Investment Management Inc.	422,677	$67.34M	0.0%	+5.2%	0.671%
2/13/2023	Deutsche Bank AG	179,714	$28.63M	0.0%	-1.6%	0.285%
2/13/2023	Callan Capital LLC	15,864	$2.53M	0.3%	N/A	0.025%
2/13/2023	Northeast Financial Consultants Inc	3,270	$0.52M	0.0%	N/A	0.005%
2/13/2023	Baird Financial Group Inc.	20,033	$3.19M	0.0%	-12.2%	0.032%
2/13/2023	Panagora Asset Management Inc.	8,162	$1.30M	0.0%	+15.2%	0.013%
2/13/2023	Ossiam	4,756	$0.76M	0.0%	-28.0%	0.008%
2/13/2023	Wells Fargo & Company MN	104,651	$16.67M	0.0%	-11.6%	0.166%
2/13/2023	Barclays PLC	72,949	$11.62M	0.0%	+67.7%	0.116%
2/13/2023	Renaissance Technologies LLC	1,290,015	$205.51M	0.3%	-0.7%	2.049%
2/13/2023	The Manufacturers Life Insurance Company	132,212	$21.06M	0.0%	+0.1%	0.210%
2/13/2023	Credit Suisse AG	117,634	$18.74M	0.0%	+7.7%	0.187%
2/13/2023	Martingale Asset Management L P	102,045	$16.26M	0.3%	+12.8%	0.162%
2/13/2023	Neuberger Berman Group LLC	3,814	$0.61M	0.0%	-2.3%	0.006%
2/13/2023	Geode Capital Management LLC	936,615	$149.05M	0.0%	+7.0%	1.487%
2/13/2023	American Century Companies Inc.	38,924	$6.20M	0.0%	+47.2%	0.062%
2/13/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	28,326	$4.51M	0.0%	+14.0%	0.045%
2/13/2023	CIBC Private Wealth Group LLC	60,465	$9.63M	0.0%	-2.1%	0.096%
2/13/2023	JPMorgan Chase & Co.	2,851,494	$454.27M	0.1%	-18.8%	4.528%
2/13/2023	Rhenman & Partners Asset Management AB	128,000	$20.39M	2.1%	-2.7%	0.203%
2/13/2023	Teacher Retirement System of Texas	11,941	$1.90M	0.0%	+33.9%	0.019%
2/13/2023	Quadrant Capital Group LLC	512	$82K	0.0%	+138.1%	0.001%
2/13/2023	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	5,487	$0.87M	0.0%	-11.0%	0.009%
2/10/2023	Ontario Teachers Pension Plan Board	15,867	$2.53M	0.0%	+76.0%	0.025%
2/10/2023	Bank of America Corp DE	285,579	$45.50M	0.0%	-19.8%	0.454%
2/10/2023	Creative Planning	1,877	$0.30M	0.0%	-23.4%	0.003%
2/10/2023	American International Group Inc.	98,051	$15.62M	0.1%	-0.9%	0.156%
2/10/2023	Amalgamated Bank	45,662	$7.27M	0.1%	+1.1%	0.073%
2/10/2023	Sei Investments Co.	57,428	$9.15M	0.0%	+16.1%	0.091%
2/10/2023	New York Life Investment Management LLC	1,627	$0.26M	0.0%	N/A	0.003%
2/10/2023	Globeflex Capital L P	965	$0.15M	0.0%	-15.3%	0.002%
2/10/2023	Schroder Investment Management Group	149,620	$23.84M	0.0%	+10.0%	0.238%
2/10/2023	GW&K Investment Management LLC	340,912	$54.31M	0.6%	-2.6%	0.541%
2/10/2023	AXQ Capital LP	1,474	$0.24M	0.2%	N/A	0.002%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	213,014	$33.94M	0.2%	+72.7%	0.338%
2/10/2023	Aviva PLC	8,320	$40.29M	0.2%	-90.4%	0.013%
2/10/2023	Victory Capital Management Inc.	546,959	$87.14M	0.1%	-32.2%	0.869%
2/10/2023	Franklin Resources Inc.	1,275,678	$203.23M	0.1%	+2.2%	2.026%
2/10/2023	Advisor Group Holdings Inc.	10,862	$1.73M	0.0%	+31.7%	0.017%
2/10/2023	Aigen Investment Management LP	1,389	$0.22M	0.0%	N/A	0.002%
2/10/2023	Brandywine Global Investment Management LLC	341,548	$54.41M	0.4%	+3.8%	0.542%
2/10/2023	PNC Financial Services Group Inc.	10,390	$1.66M	0.0%	-4.4%	0.016%
2/10/2023	Mitsubishi UFJ Trust & Banking Corp	35,806	$5.70M	0.0%	+4.7%	0.057%
2/10/2023	Vanguard Personalized Indexing Management LLC	3,897	$0.62M	0.0%	-35.7%	0.006%
2/10/2023	Tredje AP fonden	12,671	$2.02M	0.0%	+3.0%	0.020%
2/10/2023	CI Investments Inc.	1,208	$0.19M	0.0%	+14.7%	0.002%
2/10/2023	abrdn plc	22,905	$3.65M	0.0%	+7.3%	0.036%
2/9/2023	Fairbanks Capital Management Inc.	22,359	$3.56M	3.2%	-19.8%	0.036%

Data available starting January 2016

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Today's Range

Now: $145.81

$144.43

$145.99

50 Day Range

MA: $145.92

$133.98

$157.77

52 Week Range

Now: $145.81

$125.36

$169.98

Volume

101,628 shs

Average Volume

523,470 shs

Market Capitalization

$9.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of Jazz Pharmaceuticals?: Jazz Pharmaceuticals' top insider shareholders include:
Bruce C Cozadd (CEO)
Bruce C Cozadd (CEO)
Robert Iannone (EVP)
Neena M Patil (Insider)
Renee D Gala (CFO)
Kim Sablich (EVP)
Finbar Larkin (SVP)
Kenneth W O'keefe (Director)
Patrick G Enright (Director)
Christopher J Tovey (COO)
Peter Gray (Director)
Samantha Pearce (SVP)
Anne Oriordan (Director)
Patricia Carr (CAO)
Patricia Carr (SVP)
Jennifer E Cook (Director)
Elmar Schnee (Director)
James E Flynn (Insider)
Mark Douglas Smith (Director)
Learn More about top insider investors at Jazz Pharmaceuticals.
Who are the major institutional investors of Jazz Pharmaceuticals?: Jazz Pharmaceuticals' top institutional investors include:
JPMorgan Chase & Co. — 4.53%
LSV Asset Management — 3.26%
Renaissance Technologies LLC — 2.05%
Franklin Resources Inc. — 2.03%
Polaris Capital Management LLC — 1.99%
Geode Capital Management LLC — 1.49%
Learn More about top institutional investors of Jazz Pharmaceuticals stock.
Which major investors are selling Jazz Pharmaceuticals stock?: Within the previous quarter, JAZZ stock was sold by these institutional investors:
JPMorgan Chase & Co.
Point72 Asset Management L.P.
Victory Capital Management Inc.
Victory Capital Management Inc.
Victory Capital Management Inc.
Bank of Nova Scotia
Polaris Capital Management LLC
Dimensional Fund Advisors LP
In the previous year, company insiders that have sold Jazz Pharmaceuticals company stock include:
Bruce C Cozadd (CEO)
Bruce C Cozadd (CEO)
Robert Iannone (EVP)
Neena M Patil (Insider)
Renee D Gala (CFO)
Kim Sablich (EVP)
Finbar Larkin (SVP)
Kenneth W O'keefe (Director)
Patrick G Enright (Director)
Christopher J Tovey (COO)
Peter Gray (Director)
Samantha Pearce (SVP)
Anne Oriordan (Director)
Patricia Carr (CAO)
Learn More investors selling Jazz Pharmaceuticals stock.
Which major investors are buying Jazz Pharmaceuticals stock?: During the last quarter, JAZZ stock was acquired by institutional investors including:
Avidity Partners Management LP
Pacer Advisors Inc.
LSV Asset Management
Two Sigma Investments LP
Arrowstreet Capital Limited Partnership
Allspring Global Investments Holdings LLC
Two Sigma Advisers LP
Connor Clark & Lunn Investment Management Ltd.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

JAZZ Insider Trading

Jazz Pharmaceuticals Insider Trading History Chart

Jazz Pharmaceuticals Share Price & Price History

Jazz Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Jazz Pharmaceuticals (NASDAQ:JAZZ)

Institutional Buying and Selling by Quarter

Jazz Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Jazz Pharmaceuticals?

Who are the major institutional investors of Jazz Pharmaceuticals?

Which major investors are selling Jazz Pharmaceuticals stock?

Which major investors are buying Jazz Pharmaceuticals stock?